Citadel Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.8M Buy
2,098,476
+1,609,250
+329% +$12.8M ﹤0.01% 2402
2025
Q4
$2.95M Sell
489,226
-309,808
-39% -$1.84M ﹤0.01% 5195
2025
Q3
$4.56M Sell
799,034
-2,665,883
-77% -$13.6M ﹤0.01% 4528
2025
Q2
$17.5M Buy
3,464,917
+1,847,689
+114% +$9.91M ﹤0.01% 2307
2025
Q1
$10.5M Buy
1,617,228
+1,345,964
+496% +$12M ﹤0.01% 2792
2024
Q4
$1.99M Buy
271,264
+2,292
+0.9% +$18.1K ﹤0.01% 5642
2024
Q3
$2.01M Sell
268,972
-481,015
-64% -$4.18M ﹤0.01% 5519
2024
Q2
$6.67M Sell
749,987
-2,657,845
-78% -$25.5M ﹤0.01% 3323
2024
Q1
$34.5M Buy
3,407,832
+369,884
+12% +$3.77M 0.01% 1522
2023
Q4
$30.6M Buy
3,037,948
+2,954,409
+3,537% +$27M 0.01% 1603
2023
Q3
$783K Buy
83,539
+19,568
+31% +$279K ﹤0.01% 7084
2023
Q2
$1.57M Sell
63,971
-267,822
-81% -$6.73M ﹤0.01% 5605
2023
Q1
$7.72M Buy
331,793
+303,587
+1,076% +$7.76M ﹤0.01% 3150
2022
Q4
$714K Sell
28,206
-93,754
-77% -$2.3M ﹤0.01% 7499
2022
Q3
$2.35M Buy
+121,960
New +$3.1M ﹤0.01% 5285
2022
Q1
Sell
-590,876
Closed -$17.5M 14650
2021
Q4
$24.7M Buy
590,876
+451,777
+325% +$17.7M 0.01% 1787
2021
Q3
$6.05M Buy
139,099
+108,342
+352% +$4.69M ﹤0.01% 3943
2021
Q2
$1.45M Buy
30,757
+17,612
+134% +$801K ﹤0.01% 7389
2021
Q1
$674K Sell
13,145
-11,341
-46% -$611K ﹤0.01% 9028
2020
Q4
$656K Sell
24,486
-46,153
-65% -$1.5M ﹤0.01% 7633
2020
Q3
$2.42M Sell
70,639
-93,890
-57% -$4.04M ﹤0.01% 4372
2020
Q2
$6.74M Buy
+164,529
New +$5.52M ﹤0.01% 2677
2020
Q1
Sell
-19,297
Closed -$243K 10243
2019
Q4
$243K Buy
+19,297
New +$259K ﹤0.01% 7900

Other funds holding VIR